Indivior Pharmaceuticals (INDV) Total Debt (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Total Debt of $486.0 million for Q1 2026, up 47.72% year-over-year from $329.0 million in Q1 2025, and up 52.35% quarter-over-quarter from $319.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Total Debt (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Total Debt history runs 6 years deep, the most recent figure standing at $486.0 million for Q1 2026.
- In Q1 2026, Total Debt rose 47.72% year-over-year to $486.0 million; the TTM figure through Mar 2026 stood at $486.0 million (up 47.72% YoY), while the FY2025 annual figure was $319.0 million, down 4.2% from the prior year.
- Total Debt for Q1 2026 stood at $486.0 million, up from $319.0 million in the prior quarter.
- The five-year high for Total Debt was $486.0 million in Q1 2026, with the low at $240.0 million in Q4 2022.
- The 5-year median for Total Debt is $324.0 million (2025), against an average of $324.4 million.
- The sharpest annual moves came in 2025 and 2026: Total Debt dropped 4.2% in 2025, then surged 47.72% in 2026.
- Indivior Pharmaceuticals' Total Debt stood at $240.0 million in 2022, then changed by 0.0% to $240.0 million in 2023, then soared by 38.75% to $333.0 million in 2024, then dropped by 4.2% to $319.0 million in 2025, then surged by 52.35% to $486.0 million in 2026.
- Business Quant data shows INDV's Total Debt at $486.0 million in Q1 2026, $319.0 million in Q4 2025, and $322.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 760.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.54 Bn | 4.31 Bn | 294.00 Mn | 487.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 487.00 Mn |
| Mar 31, 2026 | 486.00 Mn |
| Dec 31, 2025 | 319.00 Mn |
| Sep 30, 2025 | 322.00 Mn |
| Jun 30, 2025 | 326.00 Mn |
| Mar 31, 2025 | 329.00 Mn |
| Dec 31, 2024 | 333.00 Mn |
| Dec 31, 2023 | 240.00 Mn |
| Dec 31, 2022 | 240.00 Mn |
| Dec 31, 2021 | 242.00 Mn |